BMO Capital Starts Aktis Oncology (AKTS) at Outperform
Tweet Send to a Friend
(Updated - August 19, 2026 5:30 AM EDT)
BMO Capital analyst David Lebowitz initiates coverage on Aktis Oncology (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BMO Capital analyst David Lebowitz initiates coverage on Aktis Oncology (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


